Danaher Corporation (LON:0R2B)

Market Cap	110.36B
Revenue (ttm)	17.51B
Net Income (ttm)	2.49B
Shares Out	n/a
EPS (ttm)	3.44
PE Ratio	44.34
Forward PE	25.44
Dividend	0.90 (0.43%)
Ex-Dividend Date	Jun 27, 2025

Volume	2,524
Average Volume	1,644
Open	207.02
Previous Close	205.17
Day's Range	206.22 - 208.87
52-Week Range	171.02 - 280.17
Beta	0.76
RSI	60.20
Earnings Date	Jul 22, 2025

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manuf...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1969
• Employees: 63,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0R2B

Financial Performance

In 2024, Danaher's revenue was $23.88 billion, a decrease of -0.06% compared to the previous year's $23.89 billion. Earnings were $3.90 billion, a decrease of -17.79%.

Financial numbers in USD